Quantcast
Last updated on April 21, 2014 at 8:40 EDT

Latest brain metastasis Stories

2013-12-03 23:26:13

RSSearch™ Patient Registry study highlights include demographics, SRS/SBRT treatment patterns and brain and liver metastases outcomes. (PRWEB) December 03, 2013 The Radiosurgery Society® (the RSS), a non-profit organization of medical professionals dedicated to advancing the science and clinical practice of stereotactic body radiotherapy (SBRT) and radiosurgery (SRS), announced that the first report from the RSSearch™ Patient Registry, a multi-institutional, observational...

2013-11-19 12:29:24

HAIFA, Israel, Nov. 19, 2013 /PRNewswire/ -- Novocure announced today that the first patients have enrolled in the EF-21 Study, a prospective randomized clinical study of NovoTTF(TM) Therapy for patients with brain metastases from non-small cell lung carcinoma (NSCLC) cancer. NovoTTF Therapy is an anti-mitotic treatment delivered continuously throughout the day by the NovoTTF-100A System. "The EF-21 Study builds on extensive preclinical research on the effect of NovoTTF Therapy in...

2013-09-23 13:04:18

When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. Younger patients (under 50 years old) were also found to be at no greater risk of new brain metastases developing despite omission of WBRT. A highly advanced...

2013-08-28 08:27:11

Anchorage clinic installs first and only dedicated intracranial radiosurgery system in the state ANCHORAGE, Alaska, Aug. 28, 2013 /PRNewswire/ -- In Alaska's vast expanse of over 586,000 square miles, Anchorage Radiation Therapy Center (ARTC) will be the first Alaskan clinic to offer dedicated brain stereotactic radiosurgery (SRS) with its acquisition of Elekta's Leksell Gamma Knife® Perfexion(TM) system. Beginning in December 2013, ARTC will start to use Perfexion to treat patients...

2013-04-25 08:35:14

NEW ORLEANS, April 25, 2013 /PRNewswire/ -- At the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting April 27-May 1 at the Ernest N. Morial Convention Center, Elekta (booth #2239) will spotlight the continuing preeminence of Gamma Knife® stereotactic radiosurgery (SRS) as the gold standard for treating benign and malignant brain tumors, plus other functional and vascular brain disorders. "As the only radiosurgery device designed and dedicated to the...

2013-02-06 09:47:41

Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American Association for Cancer Research. Currently, most deaths from breast cancer are a result of metastatic disease. New research shows that cancer stem-like cells – commonly defined as cells within a tumor with the capacity to initiate a new tumor, proliferate...

2013-02-05 08:36:24

RICHLAND, Wash., Feb. 5, 2013 /PRNewswire/ -- IsoRay Inc. (AMEX: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the presentation video by Cornell Weill demonstrating their techniques in the successful treatment of metastatic brain cancers using IsoRay's patented Cesium-131 (Cs-131) sutured seeds. Dr. Theodore H. Schwartz and Dr. Gabriella Wernicke, both of Weill Cornell Medical Center, presented their findings...

2012-09-27 02:27:15

GLASGOW, Scotland, Sept. 27, 2012 /PRNewswire/ -- Clinicians at one of the UK's largest radiotherapy departments have commenced brain radiosurgery treatments that enable patients to spend less time on the treatment table while aiding precision by minimizing the chance of movement during treatment. Doctors at the Beatson West of Scotland Cancer Centre in Glasgow have begun delivering the pioneering treatments using a TrueBeam(TM) STx linear accelerator from Varian Medical Systems (NYSE: VAR)....

2011-04-02 01:45:44

Biomarkers help predict lung cancer patients whose disease could spread to the brain Conducting genetic profiles using microRNA can help doctors predict which lung cancer patients are likely to also develop brain metastasis (BM), according to a study published today by Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The study identified microRNA-328 as a potential therapeutic target because of its association with the spread of cancer to the brain in patients...

2011-02-10 16:48:26

A small piece of genetic material stops the activity of an enzyme known to promote the spread of breast tumors to the brain, said a group of researchers at Baylor College of Medicine. "We have shown that the enzyme heparanase is an important mediator of brain metastasis (breast cancer spread to the brain)," said Dr. Dario Marchetti, lead author and professor of pathology and immunology, cell and molecular biology at BCM and member of the NCI-designated Dan L. Duncan Cancer Center at the...